BUZZ-Capricor gains after $150 mln equity raise in wake of its soaring stock

Reuters12-05 22:02
BUZZ-Capricor gains after $150 mln equity raise in wake of its soaring stock

** Capricor Therapeutics' CAPR.O shares up 4.5% premarket at $26.55 after co capitalizes on its soaring stock by raising equity

** San Diego, California-based biotech early Fri sells 6 mln shares at $25 for $150 mln gross proceeds

** On Weds, CAPR shares surged 371% to an 8-year high after co said its experimental cell therapy, deramiocel, slowed the progression of Duchenne muscular dystrophy (DMD) in a late-stage trial

** On Thurs, shares fell ~15% to $25.40

** Co intends to use net offering proceeds for continued development and manufacturing of its product candidates, working capital and general purposes

** Piper Sandler and Oppenheimer are joint bookrunners

** CAPR has ~45.7 mln shares outstanding

** All 10 analysts rate CAPR "strong buy" or "buy"; median PT of $44 up from $21.50 a month ago, per LSEG

(Lance Tupper is a Reuters market analyst. The views expressed are his own)

((lance.tupper@tr.com 1-646-279-6380))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment